Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AXL | P30530 | 1/20 | 0.35 |
| ▸ | JAK1 | P23458 | 1/20 | 0.34 |
| ▸ | JAK3 | P52333 | 1/20 | 0.34 |
| ▸ | USP1 | O94782 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | IDH1 | O75874 | 2/20 | 0.32 |
| ▸ | MAP4K1 | Q92918 | 2/20 | 0.31 |
| ▸ | FLT4 | P35916 | 1/20 | 0.31 |
| ▸ | KDR | P35968 | 1/20 | 0.31 |
| ▸ | PFKFB3 | Q16875 | 2/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24309763 | 0.87 | USP1 (0.33) | AXLJAK1JAK3USP1TRPA1 | |
| SCHEMBL24310657 | 0.84 | AXL (0.31) | AXLJAK1JAK3USP1TRPA1 | |
| SCHEMBL24309345 | 0.84 | JAK1 (0.32) | AXLJAK1JAK3USP1TRPA1 | |
| SCHEMBL24309663 | 0.83 | GPR39 (0.37) | AXLJAK1JAK3 | |
| SCHEMBL24309791 | 0.80 | AXL (0.33) | AXLJAK1JAK3USP1FLT4 | |
| SCHEMBL24310671 | 0.79 | JAK2 (0.36) | AXLJAK1JAK3USP1KDR | |
| SCHEMBL24309696 | 0.79 | HSP90AA1 (0.35) | USP1TRPA1LMNA | |
| SCHEMBL24309932 | 0.78 | CCNT1 (0.33) | MAP4K1PFKFB3 | |
| SCHEMBL24309750 | 0.78 | HTR1A (0.43) | AXLJAK1JAK3USP1KDR | |
| SCHEMBL29566741 | 0.78 | HTR1A (0.43) | AXLJAK1JAK3USP1KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022076627-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |